Formulation and evaluation of reconstitutable suspensions containing ibuprofen-loaded Eudragit microspheres

Acta Poloniae Pharmaceutica - Drug Research

Volumn 68, Issue 4, 2011, Pages 593-599

  Devrim, Burcu ^a   Bozkir, Asuman ^a   Canefe, Kandemir ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

D sorbitol; Ibuprofen; Microspheres; Reconstitutable suspension

Indexed keywords

BENZOIC ACID; CITRATE SODIUM; CITRIC ACID; DODECYL SULFATE SODIUM; EUDRAGIT RS; IBUPROFEN; MICROSPHERE; POLYACRYLIC ACID; SORBITOL; XANTHAN;

ARTICLE; DIFFUSION; DRUG FORMULATION; DRUG RELEASE; DRUG SCREENING; DRUG STORAGE; EMULSION; FLOW KINETICS; PALATABILITY; PARTICLE SIZE; PH; SEDIMENTATION; SUSPENSION;

ACRYLIC RESINS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BUFFERS; CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; DRUG COMPOUNDING; HYDROGEN-ION CONCENTRATION; IBUPROFEN; KINETICS; MICROSPHERES; PARTICLE SIZE; POLYSACCHARIDES, BACTERIAL; RHEOLOGY; SOLUBILITY; SORBITOL; SUSPENSIONS; TASTE; TECHNOLOGY, PHARMACEUTICAL;

EID: 79959587866     PISSN: 00016837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Rhodes C.T.: in Modern Pharmaceutics, Banker G.S., Rhodes C.T. Eds., p. 339, Dekker, New York 1990.
2. Bodmeier R., Chen H., Tyle P., Jarosz P.: J. Control. Release 15, 65 (1991).
3. Anal A.K., Stevens W.F.: Int. J. Pharm. 290, 45 (2005).
4. Dalal P.S., Narurkar M.M.: Int. J. Pharm. 73, 157 (1991).
5. Kawashima Y., Iwamoto T., Niwa T., Takeuchi H., Hino T.: Int. J. Pharm. 89, 9 (1993).
6. Lewis L., Boni R.L., Adeyeye C.M.: J. Microencapsul. 15, 555 (1998).
7. Morales M.E., Ruiz M.A., López G., Gallardo V.: Drug Dev. Ind. Pharm. 36, 885 (2010).
8. Shah K.P., Chafetz L.: Int. J. Pharm. 109, 271 (1994).
9. th edn., Gennaro A.R. Ed., Chapter 62, Mack Publishing Company, Easton 2000.
10. Adeyeye C.M., Price J.C.: Pharm. Res. 8, 1377 (1991).
11. Al-Kassas R.S., Gilligan C.A., Li Wan Po A.: Int. J. Pharm. 94, 59 (1993).
12. Gallardo A., Eguiburu J.L., Berridi M.J.F., Román J.S.: J. Control. Release 55, 171 (1998).
13. Borovac T., Pelage J.P., Kasselouri A., Prognon P., Guiffant G., Laurent A.: J. Control. Release 115, 266 (1999).
14. Kawashima Y., Niwa T., Handa T., Takeuchi H., Iwamoto T., Itoh K.: J. Pharm. Sci. 78, 68 (1989).
15. Kawashima Y., Iwamoto T., Niwa T., Takeuchi H., Hino T.: J. Microencapsul. 10, 329 (1993).
16. Nocent M., Bertochhhi L., Espitalier F., Baron B., Couarraze G.: J. Pharm. Sci. 90, 1620 (2001).
17. Sato Y., Kawashima Y., Taceuchi H., Yamamoto H.: Eur. J. Pharm. Biopharm. 20, 1 (2003).
18. Devrim B., Canefe K.: Eur. J. Pharm. Sci. 23, S40 (2004).
19. Devrim B., Canefe K.: Acta Pol. Pharm. Drug Res. 63, 521 (2006).
20. Tiwary A.K., Panpalia G.M.: Pharm. Res. 16, 261 (1999).
21. Elkheshen S.A., Abd El-Gawad N.A., Badawi A.A.: Pharm. Ind. 59, 439 (1997).
22. The United States Pharmacopoeia (XXVII), The United States Pharmacopoeial Convention, Inc., Rockville 2005.
23. Katzbauer B.: Polym. Degrad. Stab. 59, 81 (1998).
24. Ntawukulilyayo J.D., De Smedt S.C., Demeester J., Remon J.P.: Int. J. Pharm. 128, 73 (1996).
25. Garcia-Ochoa F., Santos V.E., Casas J.A., Gomez E.: Biotechnol. Adv. 18, 549 (2000).